Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults

Consultation comments and responses (PDF 4.01 MB)

Committee member list (PDF 124 KB)

Draft guidance consultation

Evidence review - Safe withdrawal (PDF 6.24 MB)

Evidence review - Withdrawal symptoms (PDF 3.76 MB)

Evidence review - Risk Factors for Dependence or Withdrawal (PDF 2.36 MB)

Evidence review - Monitoring Content and Frequency (PDF 1.3 MB)

Evidence review - Patient information (PDF 1.99 MB)

Evidence review - Prescribing strategies  (PDF 1.83 MB)

Report appendices methodology chapter (PDF 550 KB)

Evidence review Benzodiazepine Economic Analysis Report (PDF 1.03 MB)

Comments form Acknowledgements (PDF 91 KB)

Committee member list (PDF 76 KB)

Comments form 1 (MSWord 38 KB)

Draft guideline (PDF 440 KB)

Search strategies (PDF 2.76 MB)

Review questions (PDF 86 KB)

Economic plan (PDF 105 KB)

Statement - Acknowledgements (PDF 91 KB)

Register of interests (PDF 837 KB)

Committee meeting

Minutes 27 November 2019 (PDF 249 KB)

Minutes (PDF 200 KB)

Minutes (PDF 224 KB)

Minutes (PDF 164 KB)

Minutes (PDF 171 KB)

Minutes (PDF 164 KB)

Consultation comments and responses (PDF 1.68 MB)

Final scope (PDF 311 KB)

Draft scope consultation

Draft scope (PDF 287 KB)

Comments form (MSWord 34 KB)

Workshop notes Group 1 (PDF 181 KB)

Workshop notes Group 2 (PDF 186 KB)

Workshop notes Group 3 (PDF 202 KB)